Individual characteristics of non-cooled neonates with hypoxia-ischaemic encephalopathy
Second-line anticonvulsant | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Case | Clinical Sarnat | Recorded seizure burden (min) | Seizure number (n) | Mean seizure duration (s) | Age at first EEG seizure | Age at first-line anticonvulsant | Time from EEG seizure onset to treatment | Age | Total dose | Other drugs |
C1S | 2 | 38 | 4 | 574 | 10 h 15 m | N | N | M | ||
C2 | 3 | 106 | 43 | 147 | 18 h | 23 h 14 m | Pt=10 mg/kg | M | ||
C3S | 2 | 116 | 21 | 331 | 26 h 11 m | 8 h 5 m | B | 25 h 5 m | Pt=20 mg/kg | |
C4S | 3 | 137 | 84 | 98 | 14 h 12 m | N | N | M, Tr | ||
C5S | 2 | 152 | 99 | 92 | 22 h 30 m | 22 h 34 m | 4 m | 32 h 44 m | Pt=20 mg/kg | |
C6E, S | 2 | 172 | 21 | 493 | 25 h 30 m | 19 h 13 m | B | 28 h 28 m | Pt=20 mg/kg | |
C7E | 3 | 183 | 121 | 91 | 12 h 40 m | 12 h 20 m | B | 35 h 35 m | Mz=100 mcg/kg | M |
C8E | 3 | 199 | 41 | 291 | 17 h 7 m | 10 h 50 m | B | M | ||
C9 | 3 | 206 | 60 | 206 | 12 h 20 m | 24 h 24 m | 12 h 4 m | M | ||
C10E, S | 2 | 212 | 66 | 193 | 10 h 54 m | 10 h 10 m | B | 28 h 40 m | Pt=20 mg/kg | |
C11 | 3 | 239 | 150 | 96 | 10 h 56 m | 19 h 35 m | 8 h 39 m | |||
C12E | 3 | 384 | 209 | 110 | 21 h 58 m | 2 h 30 m | B | Pt=20 mg/kg | Cn, M | |
C13E, S | 2 | 413 | 63 | 393 | 17 h 54 m | 10 h 3 m | B | |||
C14E, S | 3 | 640 | 305 | 126 | 16 h 48 m | 18 h 13 m | 1 h 25 m | 29 h 13 m | Pt=20 mg/kg | Pr, Mz, Py |
C15E | 3 | 958 | 190 | 303 | 27 h 28 m | 6 h 34 m | B | 9 h 44 m | Pt=5 mg/kg | Mz, Py |
C16E | 3 | 1002 | 201 | 299 | 20 h 35 m | 16 h 37 m | B | 26 h 47 m | Pt=40 mg/kg | M, D |
B, clinically treated before EEG commenced; C, neonates enrolled from the Cork University Maternity Hospital; Cn, clonazepam; D, intravenous diazepam; E, neonates with status epilepticus; M, morphine; Mz, midazolam; N, not given any anticonvulsant; Pr, paraldehyde; Pt, phenytoin; Py, pyridoxine; S, neonates who were already seizing at the time when EEG was commenced; Tr, trichloral hydrate.